Biodegradable Controlled Drug Delivery Platform Based on Carboxylated Mesoporous Silica Nanoparticles––Zinc Oxide Quantum Dots
Industrial & Engineering Chemistry Research,
Год журнала:
2024,
Номер
63(31), С. 13459 - 13468
Опубликована: Июль 24, 2024
A
biodegradable
delivery
platform
is
constructed
for
controlled
drug
delivery.
Carboxylated
mesoporous
silica
nanoparticles
(COOH–BMSNs)
are
synthesized
to
load
the
chemotherapy
methotrexate
(MTX),
and
mesopores
of
BMSN
blocked
by
ZnO
quantum
dots
(QDs)
through
an
amidation
reaction
encapsulate
loaded
MTX.
The
QDs
decomposed
under
mildly
acidic
conditions
which
characteristic
a
tumor
microenvironment,
resulting
in
release
MTX;
additionally,
glutathione
(GSH)
can
reduce
disulfide
bonds
(−S–S−)
into
sulfhydryl
(−SH),
causing
decomposition
Therefore,
responsiveness
pH
GSH
MTX
be
achieved
with
ZnO–BMSN–MTX.
Notably,
vitro
cytotoxicity
testing
reveals
that
drug-free
carrier
(ZnO–BMSN)
exhibits
good
biocompatibility,
whereas
(ZnO–BMSN–MTX)
significant
against
SMMC-7721
cells
benefiting
from
synergistic
effect
Zn2+.
Язык: Английский
A stimuli-responsive drug delivery system based on konjac glucomannan, carboxymethyl chitosan and mesoporous polydopamine nanoparticles
Zherui Zhao,
Wanting Shi,
Yufei Wu
и другие.
International Journal of Biological Macromolecules,
Год журнала:
2024,
Номер
unknown, С. 139196 - 139196
Опубликована: Дек. 1, 2024
Язык: Английский
Synthesis of novel composite hydrogel based on carboxymethyl cellulose/acrylamide/β-cyclodextrin for drug delivery
International Journal of Biological Macromolecules,
Год журнала:
2024,
Номер
unknown, С. 138387 - 138387
Опубликована: Дек. 1, 2024
Язык: Английский
Degradable chiral mesoporous silica nanoparticles and carboxymethyl chitosan/cystamine hydrogels for selective loading and controlled release of S-naproxen
International Journal of Biological Macromolecules,
Год журнала:
2024,
Номер
288, С. 138706 - 138706
Опубликована: Дек. 11, 2024
Язык: Английский
Dual-Functional Drug Delivery System for Bisphosphonate-Related Osteonecrosis Prevention and Its Bioinspired Releasing Model and In Vitro Assessment
ACS Omega,
Год журнала:
2023,
Номер
8(29), С. 26561 - 26576
Опубликована: Июль 14, 2023
Clindamycin
(CDM)/geranylgeraniol
(GGOH)-loaded
plasma-treated
mesoporous
silica
nanoparticles/carboxymethyl
chitosan
composite
hydrogels
(CHG60
and
CHG120)
were
developed
for
the
prevention
of
medication-related
osteonecrosis
jaw
associated
with
bisphosphonates
(MRONJ-B).
The
pore
structure
performances
CHGs,
e.g.,
drug
release
profiles
kinetics,
antibacterial
activity,
zoledronic
acid
(ZA)-induced
cytotoxicity
reversal
acute
cytotoxicity,
evaluated.
bioinspired
platform
mimicking
in
vivo
fibrin
matrices
was
also
proposed
vitro/in
correlation.
CHG120
further
encapsulated
human-derived
fibrin,
generating
FCHG120.
SEM
μCT
images
revealed
interconnected
porous
structures
both
pure
fibrin-surrounding
%porosity
75
36%,
respectively,
indicating
presence
inside
hydrogel
pores,
besides
its
peripheral
region,
which
evidenced
by
confocal
microscopy.
co-presence
GGOH
moderately
decelerated
overall
releases
CDM
from
CHGs
studied
releasing
fluids,
i.e.,
phosphate
buffer
saline-based
fluid
(PBB)
simulated
interstitial
(SIF).
whole-lifetime
patterns
CDM,
fitted
Ritger-Peppas
equation,
appeared
nondifferentiable,
divided
into
two
stages,
rapid
steady
whereas
biphasic
observed
Phase
I
II
Higuchi
equations,
respectively.
Notably,
burst
drugs
subsided
lengthier
durations
(up
to
10-12
days)
SIF,
compared
those
PBB,
enabling
elicit
satisfactory
ZA
activities
MRONJ-B
prevention.
network
FCHG120
reduced
sustained
at
least
14
days,
lengthening
bactericidal
FCHG
decreasing
vitro
ovo
toxicity.
This
highlighted
significance
as
appropriate
vivo-like
platforms
evaluate
performance
an
implant.
Язык: Английский